Endothelin system in oral squamous carcinoma cells: specific siRNA targeting of ECE-1 blocks cell proliferation

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• The endothelin system, comprising endothelin-1 (ET-1) and its receptors (ET(A)R, ET(B)R), plays a role in various cancers.
• Endothelin-converting enzyme-1 (ECE-1) is crucial for producing active ET-1.
• Dysregulation of the endothelin axis is implicated in oral squamous cell carcinoma (SCC) progression.

Purpose of the Study:

• To investigate the expression and function of the endothelin axis components in human oral SCC cells.
• To determine the impact of ET-1, its receptors, and ECE-1 on oral SCC cell proliferation.
• To evaluate the therapeutic potential of targeting the endothelin system in oral cancer.

Main Methods:

• Quantitative analysis of ET-1, ET(A)R, ET(B)R, and ECE-1 isoforms in oral SCC cells versus normal keratinocytes.
• Assessment of ET-1-mediated proliferation using receptor antagonists.
• Evaluation of the effects of ECE-1 inhibition (using ECE-specific inhibitor and siRNA) on SCC cell proliferation.

Main Results:

• Oral SCC cells express ET-1, ET(A)R, ET(B)R, and ECE-1 isoforms.
• Expression of ET-1, ET(B)R, and ECE-1 is upregulated in oral SCC compared to normal cells.
• ET-1 stimulates oral SCC proliferation; ET(A)R or ET(B)R antagonism inhibits this effect.
• ECE-1 inhibition (via ECE-i or siRNA) significantly reduces oral SCC cell proliferation.

Conclusions:

• The endothelin system is actively involved in promoting oral SCC cell proliferation.
• Targeting ECE-1 or its receptors demonstrates significant antiproliferative effects on oral SCC cells.
• Modulation of the endothelin axis represents a promising novel therapeutic strategy for oral cancer.